The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
2
No.
11
March 12, 1976Mar 12, 1976
Free
DOWNLOAD THE PDF

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

Shubik Group Finally Completes Document On Carcinogenicity Criteria

Oral Contraceptives Related To Liver Tumors; New Studies Urged

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account